Cargando…

Relationships Between Various Components of Metabolic Syndrome and Chronic Kidney Disease in Shiraz, Iran

BACKGROUND: Chronic kidney disease (CKD) can potentially be associated with metabolic syndrome (MetS). OBJECTIVES: We aimed to determine the association of MetS and the number of metabolic syndrome components with the risk of CKD in the Iranian population in southern Iran. METHODS: A total of 819 su...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakhshayeshkaram, Marzieh, Roozbeh, Jamshid, Heidari, Seyed Taghi, Honarvar, Behnam, Dabbaghmanesh, Mohammad Hossein, B. Lankarani, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628220/
https://www.ncbi.nlm.nih.gov/pubmed/31372168
http://dx.doi.org/10.5812/ijem.81822
Descripción
Sumario:BACKGROUND: Chronic kidney disease (CKD) can potentially be associated with metabolic syndrome (MetS). OBJECTIVES: We aimed to determine the association of MetS and the number of metabolic syndrome components with the risk of CKD in the Iranian population in southern Iran. METHODS: A total of 819 subjects aged 18 - 88 years were enrolled using weight-based random cluster sampling. We constructed a logistic regression model to determine the adjusted odds ratios (ORs) and 95% confidence intervals (CI) of the association of MetS individual components and the number of these components with CKD. RESULTS: The prevalence rate of MetS was 25.9% (30.9% in women and 18.8% in men). CKD was present in 16.6% of the participants (men: 14% and women: 19.4%). The most prevalent component was abdominal obesity (63.6%), followed by low HDL cholesterol (36.7%), high triglyceride level (31.7%), hypertension (25.6%) and high fasting blood sugar (21.9%). Central obesity and low HDL level were observed to be more prevalent among women (P < 0.001). The presence of MetS was associated with CKD with an increased OR for CKD (OR: 3.07, 95% CI 2.09 - 4.50; P < 0.001). The adjusted ORs (95% CI) were 1.189 (0.554 - 2.555), 2.025 (0.990 - 4.141) and 4.769 (2.413 - 9.424) as the number of risk factors increased from 1 to ≥ 3. Individuals with hypertension and abdominal obesity had a higher OR of increased susceptibility to CKD in multivariate analysis. CONCLUSIONS: Our study indicated a strong association between CKD and MetS in the Iranian population. It is also suggested that individuals with metabolic risk factors should be detected earlier; they should also undergo multidisciplinary interventions to hinder worsening of the individual components of MetS and development of CKD.